Patents by Inventor Steen Knudsen

Steen Knudsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140106986
    Abstract: The present invention features microRNAs as biomarkers for prognosing cancer relapse in cancer patient. The present invention also features methods, devices, and kits for this purpose.
    Type: Application
    Filed: June 1, 2012
    Publication date: April 17, 2014
    Applicant: Medical Prognosis Institute A/S
    Inventors: Steen Knudsen, Wiktor Mazin
  • Publication number: 20140094381
    Abstract: A set of biomarkers have been identified that allows one to predict subjects who will respond to an exercise regime in term of cardiorespiratory fitness as assessed by maximal oxygen uptake. These predictions may be used, for example, to predict risk of cardiovascular disease, to design a more effective program for cardiac rehabilitation, to predict capacity for athletic performance or physically demanding occupation, and to predict ability to maintain functional capacity with aging using exercise.
    Type: Application
    Filed: September 6, 2013
    Publication date: April 3, 2014
    Applicants: Medical Prognosis Institute A/S, Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: JAMES TIMMONS, STEEN KNUDSEN, TUOMO RANKINEN, CARL JOHAN SUNDBERG, CLAUDE BOUCHARD
  • Patent number: 8445198
    Abstract: The present invention features methods, kits, and devices for predicting the sensitivity of a patient to a compound or medical treatment. The invention also features methods for identifying gene biomarkers whose expression correlates to treatment sensitivity or resistance within a patient population or subpopulation.
    Type: Grant
    Filed: May 9, 2008
    Date of Patent: May 21, 2013
    Assignee: Medical Prognosis Institute
    Inventor: Steen Knudsen
  • Publication number: 20130053275
    Abstract: The present invention features methods, devices, and kits for predicting the sensitivity of a patient to a compound or medical treatment. The invention also features methods for identifying biomarkers, the expression of which correlates to treatment sensitivity or resistance within a patient population or subpopulation.
    Type: Application
    Filed: April 29, 2011
    Publication date: February 28, 2013
    Applicant: Medical Prognosis Institute A/S
    Inventor: Steen Knudsen
  • Publication number: 20110195412
    Abstract: A set of biomarkers have been identified that allows one to predict subjects who will respond to an exercise regime in term of cardiorespiratory fitness as assessed by maximal oxygen uptake. These predictions may be used, for example, to predict risk of cardiovascular disease, to design a more effective program for cardiac rehabilitation, to predict capacity for athletic performance or physically demanding occupation, and to predict ability to maintain functional capacity with aging using exercise.
    Type: Application
    Filed: September 4, 2009
    Publication date: August 11, 2011
    Inventors: James Timmons, Steen Knudsen, Tuomo Rankinen, Carl Johan Sundberg, Claude Bouchard
  • Publication number: 20090023149
    Abstract: The present invention features methods, kits, and devices for predicting the sensitivity of a patient to a compound or medical treatment. The invention also features methods for identifying gene biomarkers whose expression correlates to treatment sensitivity or resistance within a patient population or subpopulation.
    Type: Application
    Filed: May 9, 2008
    Publication date: January 22, 2009
    Inventor: Steen Knudsen